Exact Therapeutics AS

Exact Therapeutics AS CROIC

The Cash Return on Invested Capital (CROIC) of Exact Therapeutics AS (EXTX.OL) as of Oct 18, 2026 is -235.48 %. In the previous year, Cash Return on Invested Capital (CROIC) was -70.98 % — a change of 231.75% (lower).

CROIC

-235.48 %

YoY

231.75%

Last updated:

Cash Return on Invested Capital (CROIC) of Exact Therapeutics AS is 2025 -235.48 % . Cash Return on Invested Capital (CROIC) of Exact Therapeutics AS was 2024 -70.98 % . It decreases by 231.75% lower compared to the previous year.

The Exact Therapeutics AS CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
-24.30 NOK
Jan 1, 2019
-32.80 NOK
Jan 1, 2020
-18.76 NOK
Jan 1, 2021
-52.98 NOK
Jan 1, 2022
-51.44 NOK
Jan 1, 2023
-103.58 NOK
Jan 1, 2024
-70.98 NOK
Jan 1, 2025
-235.48 NOK
The Exact Therapeutics AS CROIC history
YEARCROICYoY
-235.48 %+231.75%
-70.98 %-31.47%
-103.58 %+101.36%
-51.44 %-2.91%
-52.98 %+182.38%
-18.76 %-42.79%
-32.80 %+34.98%
-24.30 %-85.37%
-166.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Exact Therapeutics AS Stock analysis

What does Exact Therapeutics AS do? Exact Therapeutics AS is a clinical stage biopharmaceutical company headquartered in Oslo, Norway, specializing in biotechnology within the Health Care sector. The company focuses on developing a novel platform for ultrasound-mediated therapeutic amplification, specifically targeting drug enhancement through ACT sonoporation. This technology aims to amplify the clinical utility of various therapeutic agents across cancer, infectious diseases, and neurological conditions. Listed on 14 July 2020, Exact Therapeutics operates with a team of eight employees. Exact Therapeutics AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Exact Therapeutics AS stock

Cash Return on Invested Capital (CROIC) of Exact Therapeutics AS is -235.48 % in 2025.

Cash Return on Invested Capital (CROIC) of Exact Therapeutics AS changed from -70.98 % to -235.48 %, representing a 231.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Exact Therapeutics AS since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Exact Therapeutics AS with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Exact Therapeutics AS

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Exact Therapeutics AS